Skip to main content
. 2020 Feb 26;27(7):2311–2318. doi: 10.1245/s10434-020-08258-3

Table 2.

Postoperative outcomes

PVE (n = 298) No PVE (n = 1186) p-Value
Pathology diagnosis (n = 1460) 0.830
 Perihilar cholangiocarcinoma 279 (95) 1088 (93)
 Benign 6 (2) 29 (3)
 Other 8 (3) 48 (4)
Tumor-free margin (n = 1417) 185 (64) 745 (66) 0.341
Morbidity Dindo grade III or higher (n = 1474) 177 (59) 520 (44) < 0.001
Liver failure ISGLS grade B/C (n = 1472) 81 (27) 166 (14) < 0.001
Biliary leakage ISGLS grade B/C (n = 1475) 59 (20) 248 (21) 0.690
Hemorrhage ISGLS grade B/C (n = 1214) 18 (10) 61 (6) 0.078
Intra-abdominal abscess (n = 1475) 50 (17) 257 (22) 0.127
90-day mortality (n = 1484) 53 (18) 136 (12) 0.005

Data are expressed as n (%)

PVE Portal vein embolization, ISGLS International Study Group of Liver Surgery